阿尔茨海默病患者体内端粒甲基化分析

Methylation of telomeres in patients with Alzheimer’s disease

  • 摘要: 目的 探讨阿尔茨海默病(Alzheimers′Disease,AD)患者体内端粒甲基化变化规律。方法 39名AD患者,57名年龄相关的正常对照。用限制性内切酶(Moraxella Strain Producing the Enzyme I,MspI)与Haemophilus Parainfluenzae II(HpaII)评估外周血的端粒甲基化分布。结果 AD患者组MspI和HpaII内切酶的端粒平均长度与对照组相比差异均无统计学意义,但都与年龄呈负相关。在最长端粒(>9.4kb)和最短端粒(<4.4kb)长度区域,AD组端粒的甲基化程度明显高于对照组(0.28±0.16 vs 0.22±0.12,P=0.021;0.24±0.11 vs 0.46±0.15,P<0.001)。结论 提示了AD患者体内加速的年龄相关的老化特性。

     

    Abstract: Objective To study the changing rules of telomere methylation in patients with Alzheimer’s disease(AD). Methods Distribution of telomere methylation in peripheral blood of 39 patients with AD and 57 healthy controls was detected with restriction endonucleases MspI and HpaII. Results The average length of telomeres detected with MspI and HpaII in patients with AD and in healthy controls was not significantly different but negatively related with the age of patients with AD.The methylation extent of the longest telomere(>9.4kb) and the shortest telomere(<4.4kb) was significantly higher in patients with AD than in healthy controls(0.28±0.16 vs 0.22±0.12,P=0.021,0.24±0.11 vs 0.46±0.15,P<0.001). Conclusion Accelerated methylation of telomeres in patients with AD is their aging-related features.

     

/

返回文章
返回